Patrick Haley
Corporate Officer/Principal at EXELIXIS, INC.
Net worth: 10 M $ as of 31/03/2024
Profile
Patrick J.
Haley's current job is as the Executive Vice President-Commercial at Exelixis, Inc. His former job was as the Group Manager-Product at Genentech, Inc. from 2007 to 2010.
Mr. Haley completed his undergraduate degree at Duke University and holds an MBA from the Stephen M.
Ross School of Business.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
EXELIXIS, INC.
0.14% | 23/02/2024 | 419,053 ( 0.14% ) | 10 M $ | 31/03/2024 |
Patrick Haley active positions
| Companies | Position | Start |
|---|---|---|
| EXELIXIS, INC. | Corporate Officer/Principal | 01/11/2014 |
Former positions of Patrick Haley
| Companies | Position | End |
|---|---|---|
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Corporate Officer/Principal | 01/01/2010 |
Training of Patrick Haley
| Duke University | Undergraduate Degree |
| Stephen M. Ross School of Business | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| EXELIXIS, INC. | Health Technology |
| Private companies | 1 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
- Stock Market
- Insiders
- Patrick Haley
